ConductScience.org, home

Paper950590

Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients.

Sawchuk RJ and 1 other. J Pharmacokinet Biopharm, 1976. Cited by 408 papers, by iCite.

Cite this record

ConductScience Library. Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients. Papers, record 950590. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/950590

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients.
PubMed
Journal
J Pharmacokinet Biopharm
PubMed
Year
1976
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
408
iCite
Relative citation ratio, by iCite
21.7
iCite
Revised in PubMed
2019-10-21
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sawchuk RJR J
2Zaske DED E

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BurnsMajor topic
GentamicinsMajor topic
Adolescent
Adult
Child, Preschool
Half-Life
Humans
Infant
Infusions, Parenteral
Kinetics
Middle Aged

Source PubMed

Download CSV of topics

References11

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14783661Gentamicin in newborn infants. Comparison of intramuscular and intravenous administration.Am J Dis Child1973https://conductscience.org/library/papers/4783661PubMed
24842335The unpredictability of serum concentrations of gentamicin: pharmacokinetics of gentamicin in patients with normal and abnormal renal function.J Infect Dis1974https://conductscience.org/library/papers/4842335PubMed
320791473Dose of gentamicin in patients with normal renal function and renal impairment.Br Med J1968https://conductscience.org/library/papers/20791473PubMed
44993502Gentamicin dosages for renal insufficiency. Adjustments based on endogenous creatinine clearance and serum creatinine concentration.Ann Intern Med1971https://conductscience.org/library/papers/4993502PubMed
54623584Gentamicin therapy in renal failure: a nomogram for dosage.Ann Intern Med1972https://conductscience.org/library/papers/4623584PubMed
65126251Pharmacokinetics of gentamicin: distribution and plasma and renal clearance.J Infect Dis1971https://conductscience.org/library/papers/5126251PubMed
722454868Prescribing aids for gentamicin.Br J Clin Pharmacol1974https://conductscience.org/library/papers/22454868PubMed
84598849Rapid gentamicin bioassay using a multiple-antibiotic-resistant strain of Klebsiella pneumoniae.Antimicrob Agents Chemother1973https://conductscience.org/library/papers/4598849PubMed
95066760Correlation of serum creatinine concentration and gentamicin half-life.JAMA1972https://conductscience.org/library/papers/5066760PubMed
10808583Predictability of blood levels of gentamicin in man.J Infect Dis1975https://conductscience.org/library/papers/808583PubMed
114639224Clinical pharmacology of gentamicin in infants 2 to 24 months of age.Am J Dis Child1972https://conductscience.org/library/papers/4639224PubMed

Download CSV of references

Cited by111

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 408 citations.

PMIDTitleJournalYearIn PapersSource
42792002Vancomycin AUC24 Estimation for Children with Bayesian Forecasting and First-Order Equations to Update Dose Recommendations.Antibiotics (Basel)2026https://conductscience.org/library/papers/42792002PubMed
42564877Therapeutic Drug Monitoring of Vancomycin Based on Ratio of Area under the Curve to Minimum Inhibitory Concentration: A Quality Improvement Project.Can J Hosp Pharm2026https://conductscience.org/library/papers/42564877PubMed
42125915Tobramycin Pharmacokinetics in Pediatric People With Cystic Fibrosis on Maintenance Azithromycin.Pediatr Pulmonol2026https://conductscience.org/library/papers/42125915PubMed
41973123Amikacin pharmacokinetics, target attainment, and predictors in critically ill children: a retrospective cohort.Eur J Pediatr2026https://conductscience.org/library/papers/41973123PubMed
41901743Therapeutic Drug Monitoring of GS-441524 in Cats with Feline Infectious Peritonitis: Pharmacokinetic Variability and Implications for Dose Optimization.Pathogens2026https://conductscience.org/library/papers/41901743PubMed
40758132Use of nomograms based on the one-compartment model in the estimation of area under the blood concentration-time curve of vancomycin: a retrospective cohort study.Eur J Clin Pharmacol2025https://conductscience.org/library/papers/40758132PubMed
39962022
Are All Pharmacokinetic Equations Created Equal? A Comparative Analysis of Trapezoidal and Non-Trapezoidal Methods for Estimating Day 1 Area Under the Curve in Adult Hospitalized Patients with Staphylococcus aureus Bacteremia.
Infect Dis Ther2025https://conductscience.org/library/papers/39962022PubMed
39846757Multiple Model Optimal Sampling Promotes Accurate Vancomycin Area-Under-the-Curve Estimation Using a Single Sample in Critically Ill Children.Ther Drug Monit2025https://conductscience.org/library/papers/39846757PubMed
39438393Comparison of Vancomycin AUC24 Calculation Methods for Neonates and Infants.Eur J Drug Metab Pharmacokinet2024https://conductscience.org/library/papers/39438393PubMed
37368421Evaluation of Real-World Vancomycin Dosing and Attainment of Therapeutic Drug Monitoring Targets.Pharmacy (Basel)2023https://conductscience.org/library/papers/37368421PubMed
37106993Predicting the Area under the Plasma Concentration-Time Curve (AUC) for First Dose Vancomycin Using First-Order Pharmacokinetic Equations.Antibiotics (Basel)2023https://conductscience.org/library/papers/37106993PubMed
36647065Plasma concentration and eGFR in preterm and term neonates receiving gentamicin or successive amikacin therapy.BMC Pediatr2023https://conductscience.org/library/papers/36647065PubMed
35640658Does calculation method matter for targeting vancomycin area under the curve?J Antimicrob Chemother2022https://conductscience.org/library/papers/35640658PubMed
35387348Augmented Renal Clearance in Severe Infections-An Important Consideration in Vancomycin Dosing: A Narrative Review.Front Pharmacol2022https://conductscience.org/library/papers/35387348PubMed
34955835Case Report: Monitoring Vancomycin Concentrations and Pharmacokinetic Parameters in Continuous Veno-Venous Hemofiltration Patients to Guide Individualized Dosage Regimens: A Case Analysis.Front Pharmacol2021https://conductscience.org/library/papers/34955835PubMed
34664790The relationship between vancomycin AUC/MIC and trough concentration, age, dose, renal function in Chinese critically ill pediatric patients.Pharmacol Res Perspect2021https://conductscience.org/library/papers/34664790PubMed
34588940Optimization of Vancomycin Dosing to Achieve Target Area Under the Curve in Pediatrics.J Pediatr Pharmacol Ther2021https://conductscience.org/library/papers/34588940PubMed
34169543Vancomycin area under the curves estimated with pharmacokinetic equations using trough-only data.J Clin Pharm Ther2021https://conductscience.org/library/papers/34169543PubMed
33743171Pharmacokinetics and Pharmacodynamics of High-Dose Piperacillin-Tazobactam in Obese Patients.Eur J Drug Metab Pharmacokinet2021https://conductscience.org/library/papers/33743171PubMed
33526481Optimizing Aminoglycoside Dosing Regimens for Critically Ill Pediatric Patients with Augmented Renal Clearance: a Convergence of Parametric and Nonparametric Population Approaches.Antimicrob Agents Chemother2021https://conductscience.org/library/papers/33526481PubMed

See all 111 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/950590

GET https://conductscience.org/api/papers/v1/950590/cited_by?page=2